US To Spend $720 Million On Covid Treatment From Eli Lilly
The antibody drug in question is bebtelovimab, and though still experimental, it is reported to fight omicron covid. The deal will secure 600,000 doses for the Department of Health and Human Services. Separately, conflicting reports throw some doubt on monoclonal antibody treatment sotrovimab.